UNSPSC 51111768: Vindesine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C43H55N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RSA8KO39WH, chemically known as vincaleukoblastine, 3-(aminocarbonyl)-o(sup 4)-deacetyl-3-de(methoxycarbonyl)- but generally known as vindesine, which bears US NIH Compound Identifier 40839. European Medicines Agency schedules Vindesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00061MIG.

UNSPSC 51111768 Vindesine is a Commodity code, but the recent state and local opportunities tagged under it do not involve vindesine or chemotherapy agents at all. Instead, the posted solicitations track naloxone (opioid reversal medication), generic multi-source pharmaceuticals and OTC products, and medical and first aid supplies for emergency response. The code shows a substantial mismatch between its nominal scope and what state and local procurement offices are actually buying under this classification. The opportunities span health department acquisitions of naloxone and drug deactivation systems, state HHS commission market research on direct-to-manufacturer pharmacy programs, municipal fire department medical supply procurements, and cooperative purchasing alliances sourcing generic pharmaceuticals across state and local health systems. Issuing bodies include county health departments, state health and human services agencies, municipal purchasing departments, and multistate cooperative purchasing alliances. The work itself centers on acquiring pharmaceutical products, medical consumables, and OTC supplies for public health, emergency response, and state employee benefit administration rather than oncology or chemotherapy-specific agents.

Geographic activity spans Florida, Texas, and the Upper Midwest through Minnesota's multistate cooperative (which includes Oregon participation). The most recent representative opportunity is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2026 response deadline. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products across state and local facilities, due March 26, 2026, with contract effectiveness July 1, 2026. The City of Tampa's Purchasing Department posted ITB 26P00145 on March 25, 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department, closing March 13, 2026, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises. The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs, signaling early-stage market research rather than formal competitive procurement at this stage.